However, MRD positivity with CD19+ blasts persisted, and the disease later relapsed as CD19+ B-ALL with concurrent myeloid sarcoma harboring KMT2A rearrangement in the thoracic spinal cord. Here, CD19 is linked to myeloid sarcoma.